Home / Innere Medizin / Onkologie / ESMO is doing a lot for young oncologists
Dr. Claudia Cardone

ESMO is doing a lot for young oncologists

Dr. Claudia Cardone, Università Vanvitelli in Naples, Italy, is currently a research fellow at the Medical University of Vienna to investigate biomarkers in CRC. She also describes what ESMO young oncologists can do for “youngsters”.

Interview Partner(s):

Editor:

Production:

Source: ESMO 2018 Congress

Cardone C et al., AXL has a prognostic role in metastatic colorectal cancer (mCRC) and is a predictive biomarker of lack of efficacy of chemotherapy (CT) + cetuximab in RAS wild type (WT) patients (pts). Abstract #96P

Cremolini C et al., TRIBE2: a phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable metastatic colorectal cancer (mCRC) patients (pts). Abstract #LBA2

LOGIN

Login

Passwort vergessen?